Cannabis Science Inc (fka CBIS)

[Flr1]

CANNABIS SCIENCE SENIOR EXECUTIVES SET TO PRESENT DRUG DEVELOPMENT INITIATIVES TO KEY STAKEHOLDERS AROUND THE WORLD AT THE UPCOMING GLOBAL HEALTH CATALYST SUMMIT AT HARVARD MEDICAL SCHOOL NEXT WEEK, APRIL 28 - 30TH 2017

Cannabis Science Versus Cancer and Other Malignancies and the Palliative Care and Mental Health Sessions will be live-streamed to an audience worldwide

IRVINE, CA--(Marketwired - Apr 19, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is set to participate in the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Information on the GHC Summit is available at http://www.globalhealthcatalystsummit.org.

The Cannabis Science Versus Cancer and Other Malignancies and the Palliative Care and Mental Health Sessions will be live-streamed to an audience worldwide. Those interested in joining the live-streaming of these sessions, as well as any of the other GHC Summit sessions, can subscribe to the Next Generation Global Health Security Network YouTube Channel at https://www.youtube.com/channel/UCqihIfrETTl2eRMxNQxUCDQ. Additionally, the recorded sessions can be accessed via this YouTube channel.